CSI Market
Sign In | Register

Edwards Lifesciences (EW) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EW Annual Balance Sheets →
This page allows investors to track Edwards Lifesciences's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent3,110.80
Restricted Cash0.90
Short-term Investments, Total1,572.90
Cash & Short-term Investments4,682.00
Accounts receivable784.90
Other Receivables, Net, Current152.90
Inventories1,159.40
Assets held for sale50.10
Disposal Group, Including Discontinued Operation, Assets, Current AS0.00
Other current assets5.80
Prepaid Expense, Current AS147.20
Total Current Assets7,247.50
Equipment/Property/Plant Net1,858.30
Goodwill net1,951.70
Intangible Assets1,161.10
Long-term investments262.60
Long-term recivables14.80
Deferred Tax Assets, Net, Noncurrent AS414.30
Prepaid pension87.10
Disposal Group, Including Discontinued Operation, Assets, Noncurrent AS0.00
Other Assets1,147.00
Operating Lease Right Of Use Asset99.30
Deferred Income Tax Assets Net1,098.10
Total Assets14,144.40
Liabilities
Accounts Payable, Current AC199.70
Accrued Liabilities, Current AC439.70
Other accrued expenses8.50
Other current liabilities0.00
Taxes Payable, Total1,008.90
Disposal Group, Including Discontinued Operation, Liabilities, Current LI7.50
Total Current Liabilities1,576.70
Long-term debt598.80
Total Long-term Debt598.80
Estimated Litigation Liability, Noncurrent LI7.80
Liability for Uncertain Tax Positions, Noncurrent LI580.30
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent LI0.00
Other longterm liabilities419.30
Operating Lease Liability Current24.30
Operating Lease Liability Noncurrent80.10
Total Liabilities3,182.90
Stockholders' Equity
Treasury Stock Common Value-7,513.90
Common Stock Value662.30
Additional Paid In Capital Common Stock3,057.60
Retained Earnings / Accumulated Deficit15,170.60
Accumulated Other Comprehensive Income-220.20
Other Equity-220.20
Common Stockholder's Equity10,861.10
Non-controlling interests & other100.40
Total Stockholder's Equity10,961.50
Liabilities & Stockholder's Equity14,144.40
4 historic quarters locked

Sign in to unlock the full Edwards Lifesciences balance sheet history.

Sign In Create Free Account

About Edwards Lifesciences Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: November 4, 2026
  • Source: ew-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001099800-26-000054

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI